Elevance Health Inc. stock underperforms Tuesday when compared to competitors
Shares of Elevance Health Inc. ELV slid 1.24% to $391.22 Tuesday, on what proved to be an all-around positive trading session ...
CVS Health Stock Is Making a Comeback. Earnings Are the Next Hurdle.
CVS has replaced its CEO, and is working to reassure investors. The stock has jumped more than 20% in the first weeks of 2025 ...
Humana says 2025 is critical for margin recovery as quarterly loss widens
Humana backed its adjusted 2025 EPS guidance, which it has said would be "at least in line with 2024 results," or about $15.88. Adjusted EPS is expected to come to $16.25, while FactSet is expecting ...
Invesco Dividend Income Fund Q4 2024 Commentary
The fund is balanced across sectors and industries, with a focus on long-term growth areas and companies with sustainable ...
Humana's Revenue Beats Estimates
Humana posted higher-than-expected quarterly revenue, but gave an unexpectedly weak outlook for the year now under way. The Louisville, Ky., health insurer company logged a fourth-quarter loss of $693 ...
Humana Stock Slides Despite Solid Quarter Amid Weak Forecast
Investors are looking for an end to the Medicare Advantage blues when the health insurer Humana reports its fourth-quarter ...
Humana 4Q Revenue Tops Estimates, Issues FY 2025 Outlook
Humana forecast adjusted earnings per-share around $16.25 for fiscal 2025. Analysts polled by FactSet expected $16.71 a share in adjusted earnings. Write to Denny Jacob at [email protected] ...
10 growth stocks in the S&P 500's bargain sector
The S&P 500 index trades at a forward price/earnings ratio of 21.9. The U.S. large-cap benchmark stock index is weighted by market capitalization. The index's current forward P/E valuation is 18% ...